Concepedia

Saša Dimitrijević

SD

Statistics

Publications

31

Citations

14.9K

H-Index

26

Active since

2001

Affiliations

Novartis (Switzerland)(Current)

Dana-Farber Cancer Institute

Oregon Health & Science University

Fox Chase Cancer Center

Royal Marsden Hospital

Saša Dimitrijević is an author at Novartis (Switzerland) specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2001–2023

31

Publications

31

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Charles D. Blanke et al. · New England Journal of Medicine · 2002 · 4.4K citations · Full text

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich, Christopher L. Corless, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 2.3K citations

Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

Heikki Joensuu, Peter Roberts‎, Maarit Sarlomo‐Rikala et al. · New England Journal of Medicine · 2001 · 2.1K citations · Full text

, , +11

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · The Lancet · 2001 · 1.3K citations

, , +5

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Jane F. Apperley, Martine Gardembas, Junia V. Melo et al. · New England Journal of Medicine · 2002 · 630 citations · Full text

1–5 of 31